Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

The impact of first line tyrosine kinase inhibitors (TKI) on the development of resistance mutations in patients with Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL)

Virginia Tan, Jean Sabile, Amrita Desai, Arpita Gandhi, Jennifer Saultz, Gabrielle Meyers, Laura Newell, Rachel Cook, Elie Traer, Curtis Lachowiez, Ronan Swords, Richard Maziarz, Theodore Braun, Brandon Hayes-Lattin, Jessica Leonard

Blood (2025) 146 (Supplement 1): 3372.

https://doi.org/10.1182/blood-2025-3372

Published: 2025

Journal Articles

Venetoclax in combination with dasatinib, prednisone, rituximab and blinatumomab for the upfront treatment of adults with Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL), Results from a Phase 1B study

Blood (2025) 146 (Supplement 1): 3354.

https://doi.org/10.1182/blood-2025-3354

Published: 2025

Journal Articles

Telehealth based virtual consult visits and in-person consult visits provide comparable time to HLA-typing and preliminary donor search in patients referred for allogeneic hematopoietic cell transplantation

Blood (2025) 146 (Supplement 1): 1083.

https://doi.org/10.1182/blood-2025-1083

Published: 2025

Journal Articles

Comparable outcomes in patients aged ≥70 vs. <70 undergoing allogeneic transplantation with fludarabine and melphalan conditioning and post-transplant cyclophosphamide

Howard Chang, Staci Williamson, Daniel Chandra, Andy Chen, Rachel Cook, Amrita Desai, Arpita Gandhi, Brandon Hayes-Lattin, Curtis Lachowiez, Jessica Leonard, Richard Maziarz, Laura Newell, Jennifer Saultz, Ronan Swords, Elie Traer, Gabrielle Meyers

Blood (2025) 146 (Supplement 1): 6085.

https://doi.org/10.1182/blood-2025-6085

Published: 2025

Journal Articles

Low adherence to cervical cancer screening guidelines among women survivors after allogeneic hematopoietic cell transplantation: Predictors and practice gaps from a single-center analysis

Prajna Woonnimani, Amanda Bruegl, Haley Burns, Jessica Currier, Kate Bolten, Talia Frost-Belansky, Emily Van Houweling, Jennifer Saultz, Andy Chen, Jessica Leonard, Amrita Desai, Staci Williamson, Laura Newell, Brandon Hayes-Lattin, Gabrielle Meyers, Richard Maziarz, Rachel Cook, Arpita Gandhi

Blood (2025) 146 (Supplement 1): 7784.

https://doi.org/10.1182/blood-2025-7784

Published: 2025

Journal Articles

Comparison of 80 mg/kg vs. 100 mg/kg post-transplant cyclophosphamide dose with flu/mel and allogeneic transplant: Less is not more

Blood (2025) 146 (Supplement 1): 4252.

https://doi.org/10.1182/blood-2025-4252

Published: 2025

Journal Articles

FluMel100 with post-transplant cyclophosphamide: A safe and effective regimen for patients aged ≥75 years with MDS and AML

Blood (2025) 146 (Supplement 1): 7744.

https://doi.org/10.1182/blood-2025-7744

Published: 2025

Journal Articles

Elevated Placental Growth Factor Levels after Allogeneic Hematopoietic Cell Transplantation: Clinical and Peripheral Blood Mononuclear Cell Receptor Expression Correlates

Laura Newell, MD, Gabrielle Meyers, MD, Shernan G. Holtan, MD

Blood (2014) 124 (21): 5870.

https://doi.org/10.1182/blood.V124.21.5870.5870

Published: 2014

Journal Articles

Ex Vivo Pharmacologic Modulation in a Nutrient-Rich Medium to Accelerate Engraftment of Human Umbilical Cord Blood

Corey S Cutler, MD MPH, Daniel Shoemaker, PhD, Peter Westervelt, MD PhD, Daniel R. Couriel, MD, Sumithra Vasu, MBBS, Luis M. Isola, MD, Chatchada Karanes, MD, Laura Newell, MD, Betsy Rezner, BS, Lisa Guerrettaz, PhD, David Robbins, BS, Amanda Medcalf, BS, MT(ASCP), Scott Wolchko, MS, John Ferraro, MBA, Pratik S. Multani, MD MS

Blood (2014) 124 (21): 3807.

https://doi.org/10.1182/blood.V124.21.3807.3807

Published: 2014

Journal Articles

Circulating Angiogenic Factors As Biomarkers of Acute Gvhd Onset and Response to Therapy: Repair and Regeneration Versus Endothelial Damage and Inflammation

Shernan G. Holtan, MD, Michael R. Verneris, MD, Kirk R. Schultz, MD, Laura Newell, MD, Gabrielle Meyers, MD, Fiona C. He, MD, Todd E. DeFor, MS, Margaret L. MacMillan, MD, Sarah A. Cooley, MD MS, Angela Panoskaltsis-Mortari, PhD, Daniel J. Weisdorf, MD

Blood (2014) 124 (21): 2489.

https://doi.org/10.1182/blood.V124.21.2489.2489

Published: 2014

Journal Articles

Increased NKT-like Cells and Markers of T Cell Activation in Long Term Survivors of Allogeneic Hematopoietic Cell Transplantation

Shernan G. Holtan, MD, Laura Newell, MD, Rachel J Cook, MD MS, Kaitlin Pataroque, Nicky Leeborg, MD, Richard T. Maziarz, MD, Guang Fan, MD PhD

Blood (2014) 124 (21): 3958.

https://doi.org/10.1182/blood.V124.21.3958.3958

Published: 2014

Journal Articles

Pre-Transplant Ganciclovir and High-Dose Valacyclovir Prophylaxis Decrease Incidence of CMV Reactivation In High-Risk Seropositive UCBT Recipients

Filippo Milano, MD, PhD, Steven Pergam, Hu Xie, Jonathan Gutman, MD, Ivy Riffkin, Victor Chow, Laura Newell, Michael Boeckh, MD, Colleen Delaney, MD, MSc

Blood (2010) 116 (21): 678.

https://doi.org/10.1182/blood.V116.21.678.678

Published: 2010

Journal Articles

The Bispecific Anti-CD20/CD22 Antibody (Bs20x22) Has More Lymphomacidal Activity Than the Parent Antibodies Both Alone or In Combination

Laura Newell, Joseph Tuscano, MD, Yunpeng Ma, Shiloh Martin, Robert o'Donnell

Blood (2010) 116 (21): 425.

https://doi.org/10.1182/blood.V116.21.425.425

Published: 2010

Journal Articles

Purified, Fermented, Extract of Triticum Aestivum Has Significant Independent Lymphomacidal Activity and Augments the Activity of Rituximab

Laura Newell, Joseph Tuscano, MD, Robert o'Donnell, Professor, Yunpeng Ma

Blood (2010) 116 (21): 2857.

https://doi.org/10.1182/blood.V116.21.2857.2857

Published: 2010

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

The impact of first line tyrosine kinase inhibitors (TKI) on the development of resistance mutations in patients with Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL)

Venetoclax in combination with dasatinib, prednisone, rituximab and blinatumomab for the upfront treatment of adults with Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL), Results from a Phase 1B study

Telehealth based virtual consult visits and in-person consult visits provide comparable time to HLA-typing and preliminary donor search in patients referred for allogeneic hematopoietic cell transplantation

Comparable outcomes in patients aged ≥70 vs. <70 undergoing allogeneic transplantation with fludarabine and melphalan conditioning and post-transplant cyclophosphamide

Low adherence to cervical cancer screening guidelines among women survivors after allogeneic hematopoietic cell transplantation: Predictors and practice gaps from a single-center analysis

Comparison of 80 mg/kg vs. 100 mg/kg post-transplant cyclophosphamide dose with flu/mel and allogeneic transplant: Less is not more

FluMel100 with post-transplant cyclophosphamide: A safe and effective regimen for patients aged ≥75 years with MDS and AML

Elevated Placental Growth Factor Levels after Allogeneic Hematopoietic Cell Transplantation: Clinical and Peripheral Blood Mononuclear Cell Receptor Expression Correlates

Ex Vivo Pharmacologic Modulation in a Nutrient-Rich Medium to Accelerate Engraftment of Human Umbilical Cord Blood

Circulating Angiogenic Factors As Biomarkers of Acute Gvhd Onset and Response to Therapy: Repair and Regeneration Versus Endothelial Damage and Inflammation

Increased NKT-like Cells and Markers of T Cell Activation in Long Term Survivors of Allogeneic Hematopoietic Cell Transplantation

Pre-Transplant Ganciclovir and High-Dose Valacyclovir Prophylaxis Decrease Incidence of CMV Reactivation In High-Risk Seropositive UCBT Recipients

The Bispecific Anti-CD20/CD22 Antibody (Bs20x22) Has More Lymphomacidal Activity Than the Parent Antibodies Both Alone or In Combination

Purified, Fermented, Extract of Triticum Aestivum Has Significant Independent Lymphomacidal Activity and Augments the Activity of Rituximab

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only